[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619905":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":32,"locations":41,"responsibleParty":57,"collaborators":60,"id":70,"slug":18,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":75,"eligibilityCriteria":76,"healthyVolunteers":77,"sex":78,"minAge":79,"maxAge":18,"enrollmentInfo":80,"targetDuration":18,"studyType":83,"phases":84,"briefSummary":86,"conditions":87,"keywords":90,"overallStatus":44,"whyStopped":18,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"HealthNet Transcultural Psychosocial Organization","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PLA Intervention group","EXPERIMENTAL","Participatory Learning and Action (PLA) sessions adapted from the D-MAGIC trial (Bangladesh). The PLA intervention will be delivered to community members with type II diabetes to improve diabetes-related outcomes. Sessions will be group-based, lasting approximately 2-3 hours each. Participants in this arm will be followed and evaluated 10 months after the start of the intervention using a structured, validated, literature-based endline assessment checklist to assess feasibility and outcomes.",[13],"Behavioral: PLA",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care (control) group","NO_INTERVENTION","Participants in the control arm will receive standard practice (usual care) and comprehensive information about the project but will not receive the PLA intervention.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","PLA","An PLA based intervention would be carried out to prepare the individuals with TIIDM. The intervention would be carried out for a tentative time of 2 to 3 hours to educate the community. The study participants would be evaluated after completion of 10 months of the intervention. A structured, validated and literature-based end line assessment checklist will be devised to assess the feasibility of the intervention.",[9],[26],"Participatory Learning and Action",[28],{"name":29,"affiliation":30,"role":31},"Abdul Rahman Shahab, MPH","Deputy Country Director, HealthNet TPO, Afghanistan","PRINCIPAL_INVESTIGATOR",[33,37],{"name":29,"role":34,"phone":35,"phoneExt":18,"email":36},"CONTACT","+93786611325","abdul.shahab@hntpo.org",{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},"Sayed Murtaza Sadat Hofiani, MPH","+93700555600","rsch.coord@hntpo.org",[42],{"facility":43,"status":44,"city":45,"state":45,"zip":46,"country":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"HealthNet TPO, Afghanistan","RECRUITING","Kabul","24000","Afghanistan",{"type":49,"coordinates":50},"Point",[51,52],69.17233,34.52813,{"lat":52,"lon":51},[55,56],{"name":29,"role":34,"phone":35,"phoneExt":18,"email":36},{"name":38,"role":34,"phone":39,"phoneExt":18,"email":40},{"type":31,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Sayed Murtaza Sayed Murtaza Sadat Hofiani","Research coordinator, HealthNet TPO",[61,63,65,68],{"name":62,"class":6},"University of York",{"name":64,"class":6},"Khyber Medical University Peshawar",{"name":66,"class":67},"National Institute for Health Research, United Kingdom","OTHER_GOV",{"name":69,"class":6},"Aga Khan University","100619905",false,"NCT07350694","Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors","Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan","EMPOWER-D-Afg","Inclusion Criteria:\n\n* For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above.\n* Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent.\n* All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate.\n* Participants who can attend the scheduled meetings and interventions as per the study protocol.\n\nExclusion Criteria:\n\n* For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years.\n* Individuals unwilling to provide consent for participation.\n* Participants with reported health conditions that may hinder their active involvement in the study.\n* Individuals with non-compliance with research protocols",true,"ALL","20 Years",{"count":81,"type":82},250,"ESTIMATED","INTERVENTIONAL",[85],"NA","This project aims to adapt, implement, and evaluate PLA based intervention in Rural Kabul, Afghanistan for TIIDM prevention and control.",[88,89],"Diabetes Type 2","Type II Diabetes Mellitus",[91,92,89,93],"Community-Based Participatory Research","Participatory Learning and Action Research","Intermediate hyperglycemia","2026-01-11",{"date":96,"type":97},"2026-01-20","ACTUAL",{"date":99,"type":97},"2024-12-24",{"date":101,"type":82},"2027-09-30",{"name":5,"class":6},1]